{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:32:19Z","timestamp":1784424739959,"version":"3.55.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects young women and involves multiple organs, including the skin, joints, kidneys, and nervous system. In the pathogenesis of SLE, autoreactive B cells play a pivotal role through mediating antibody production, antigen presentation, and cytokine secretion. Recent studies have highlighted immunometabolism as a pivotal regulatory axis operating at both intracellular and extracellular levels during immune dysregulation. In SLE, plasma cells produce large quantities of autoantibodies, playing an important role in disease progression. This process demands a substantial energy supply, along with protein and nucleic acid synthesis, and is accompanied by dynamic reconstitution of intracellular metabolism. Furthermore, alterations in metabolic pathways not only facilitate efficient energy production but also directly modulate immune responses, including cytokine production and cell differentiation. Differences in cellular metabolism can shape B cell differentiation trajectories. Elucidating the immunometabolic mechanisms governing B cell activation and fate decisions may reveal novel drivers of lupus pathogenesis and identify new opportunities for therapeutic intervention.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1755589","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:04:05Z","timestamp":1779775445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune regulation and cell metabolism in B cell subsets in patients with systemic lupus erythematosus"],"prefix":"10.3389","volume":"17","author":[{"given":"Masanobu","family":"Ueno","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health","place":["Kitakyushu, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kubo","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health","place":["Kitakyushu, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Todoroki","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health","place":["Kitakyushu, Japan"]},{"name":"Department of Molecular Targeted Therapeutics, University of Occupational and Environmental Health","place":["Kitakyushu, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Nakayamada","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health","place":["Kitakyushu, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health","place":["Kitakyushu, Japan"]},{"name":"Department of Molecular Targeted Therapeutics, University of Occupational and Environmental Health","place":["Kitakyushu, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101814","article-title":"State-of-the-art treatment of systemic lupus erythematosus","volume":"23","author":"Tanaka","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101814","DOI":"10.1016\/j.berh.2022.101814","article-title":"Systemic lupus erythematosus","volume":"36","author":"Tanaka","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nature03724","article-title":"Cellular and genetic mechanisms of self tolerance and autoimmunity","volume":"435","author":"Goodnow","year":"2005","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2008.09.001","article-title":"B-cell tolerance checkpoints in health and autoimmunity","volume":"20","author":"Meffre","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/imr.12821","article-title":"Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies","volume":"292","author":"Meffre","year":"2019","journal-title":"Immunol Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/jci24179","article-title":"Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus","volume":"115","author":"Cappione","year":"2005","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.005","article-title":"Distinct effector B cells induced by unregulated Toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3175","article-title":"Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus","volume":"16","author":"Tipton","year":"2015","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00028","article-title":"Regulatory T cell-mediated control of autoantibody-induced inflammation","volume":"3","author":"Fujio","year":"2012","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.03.014","article-title":"Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation","volume":"129","author":"Iwata","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.40180","article-title":"Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients","volume":"69","author":"Kubo","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2018.12.017","article-title":"Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus","volume":"200","author":"Yoshikawa","year":"2019","journal-title":"Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108343","article-title":"Discovery of a novel Igbeta and FcgammaRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosus","volume":"101","author":"Kitanaga","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01957","article-title":"Up-regulation of TLR7-mediated IFN-alpha production by plasmacytoid dendritic cells in patients with systemic lupus erythematosus","volume":"9","author":"Sakata","year":"2018","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu148","article-title":"Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus","volume":"53","author":"Ruiz-Arruza","year":"2014","journal-title":"Rheumatol (Oxford)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab953","article-title":"Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus","volume":"61","author":"Miyazaki","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae495","article-title":"belimumab.pdf","volume":"64","author":"Sakai","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roac007","article-title":"Rituximab in the real-world treatment of lupus nephritis: a retrospective cohort study in Japan","volume":"33","author":"Tanaka","year":"","journal-title":"Mod Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"Muller","year":"2024","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.43","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"13","author":"Morel","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","article-title":"Pharmacological activation of pyruvate kinase M2 inhibits CD4(+) T cell pathogenicity and suppresses autoimmunity","volume":"31","author":"Angiari","year":"2020","journal-title":"Cell Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01267-0","article-title":"Immunometabolism in systemic lupus erythematosus","volume":"21","author":"Patino-Martinez","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41556-018-0217-x","article-title":"Metabolism as a guiding force for immunity","volume":"21","author":"Jung","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0291-z","article-title":"Targeting immunometabolism as an anti-inflammatory strategy","volume":"30","author":"Palsson-Mcdermott","year":"2020","journal-title":"Cell Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10753-022-01751-9","article-title":"Role of T cells in the pathogenesis of rheumatoid arthritis: Focus on immunometabolism dysfunctions","volume":"46","author":"Masoumi","year":"2023","journal-title":"Inflammation"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00365","article-title":"The role of the pentose phosphate pathway in diabetes and cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3664","article-title":"Gsk3 is a metabolic checkpoint regulator in B cells","volume":"18","author":"Jellusova","year":"2017","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.isci.2018.07.005","article-title":"Initial B cell activation induces metabolic reprogramming and mitochondrial remodeling","volume":"5","author":"Waters","year":"2018","journal-title":"iScience"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.551051","article-title":"Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation","volume":"289","author":"Dufort","year":"2014","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2026.110706","article-title":"Short-chain fatty acid deficiency drives aberrant B cell differentiation in systemic lupus erythematosus","volume":"285","author":"Kanda","year":"2026","journal-title":"Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/jci186258","article-title":"Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9","volume":"135","author":"Guo","year":"2025","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681105","article-title":"B cell metabolism and autophagy in autoimmunity","volume":"12","author":"Raza","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601908","article-title":"Metabolic reprogramming commits differentiation of human CD27(+)IgD(+) B cells to plasmablasts or CD27(-)IgD(-) cells","volume":"199","author":"Torigoe","year":"2017","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302062","article-title":"Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells","volume":"192","author":"Caro-Maldonado","year":"2014","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110939","article-title":"PI3K-dependent reprogramming of hexokinase isoforms controls glucose metabolism and functional responses of B lymphocytes","volume":"27","author":"Paradoski","year":"2024","journal-title":"iScience"},{"key":"B44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-023-44540-0","article-title":"MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation","volume":"15","author":"Chi","year":"2024","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0156-5","article-title":"Second signals rescue B cells from activation-induced mitochondrial dysfunction and death","volume":"19","author":"Akkaya","year":"2018","journal-title":"Nat Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/art.42433","article-title":"Amelioration of autoimmunity in a lupus mouse model by modulation of T-Bet-promoted energy metabolism in pathogenic age\/autoimmune-associated B cells","volume":"75","author":"Han","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004567","article-title":"Induction of interleukin 21 receptor expression via enhanced intracellular metabolism in B cells and its relevance to the disease activity in systemic lupus erythematosus","volume":"10","author":"Ueno","year":"2024","journal-title":"RMD Open"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab824","article-title":"An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus","volume":"61","author":"Sumikawa","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/art.41208","article-title":"Methionine commits cells to differentiate into plasmablasts through epigenetic regulation of BTB and CNC homolog 2 by the methyltransferase EZH2","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13761","article-title":"Viperin, through its radical-SAM activity, depletes cellular nucleotide pools and interferes with mitochondrial metabolism to inhibit viral replication","volume":"594","author":"Ebrahimi","year":"2020","journal-title":"FEBS Lett"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00385-9","article-title":"Cellular pyrimidine imbalance triggers mitochondrial DNA-dependent innate immunity","volume":"3","author":"Sprenger","year":"2021","journal-title":"Nat Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110243","article-title":"Integration of multi-omics analysis reveals metabolic alterations of B lymphocytes in systemic lupus erythematosus","volume":"264","author":"Iperi","year":"2024","journal-title":"Clin Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/s41590-023-01484-3","article-title":"Dynamic mitochondrial transcription and translation in B cells control germinal center entry and lymphomagenesis","volume":"24","author":"Yazicioglu","year":"2023","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/s41467-024-46763-1","article-title":"Defective mitochondria remodelling in B cells leads to an aged immune response","volume":"15","author":"Iborra-Pernichi","year":"2024","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107487","article-title":"Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment","volume":"26","author":"Wilson","year":"2023","journal-title":"iScience"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.602539","article-title":"Single-cell transcriptomic analyses define distinct peripheral B cell subsets and discrete development pathways","volume":"12","author":"Stewart","year":"2021","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2024.100252","article-title":"Extrafollicular CD19(low)CXCR5(-)CD11c(-) double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus","volume":"9","author":"Chizzolini","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221464","article-title":"Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus","volume":"81","author":"Takeshima","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159384","article-title":"Metabolic profiling of systemic lupus erythematosus and comparison with primary Sjogren's syndrome and systemic sclerosis","volume":"11","author":"Bengtsson","year":"2016","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead646","article-title":"Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk","volume":"63","author":"Jury","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225349","article-title":"Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology","volume":"83","author":"Carter","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212935","article-title":"Metabolic pathways and immunometabolism in rare kidney diseases","volume":"77","author":"Grayson","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100356","article-title":"Pharmacologically inferred glycolysis and glutaminolysis requirement of B cells in lupus-prone mice","volume":"208","author":"Choi","year":"2022","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680068","article-title":"Pyruvate kinase M2 contributes to TLR-mediated inflammation and autoimmunity by promoting Pyk2 activation","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00833","article-title":"Targeting T cell activation and lupus autoimmune phenotypes by inhibiting glucose transporters","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/art.40785","article-title":"Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus","volume":"71","author":"Koga","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/art.39791","article-title":"Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2023-eular.1349","article-title":"Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort study","volume":"6","author":"Bai","year":"2025","journal-title":"Rheumatol Immunol Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.04.006","article-title":"Targeting T cell metabolism to regulate T cell activation, differentiation and function in disease","volume":"46","author":"Patel","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143245","article-title":"Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice","volume":"6","author":"Wilson","year":"2021","journal-title":"JCI Insight"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(20)30004-7","article-title":"Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Sun","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.192286","article-title":"Intrinsic T cell glutaminolysis promotes autoimmunity in lupus-prone mice","volume":"10","author":"Choi","year":"2025","journal-title":"JCI Insight"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109133","article-title":"Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR\/P70S6K\/4EBP1 and NLRP3\/caspase-1\/IL-1beta pathways in MRL\/lpr mice","volume":"112","author":"Zhang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi2046","article-title":"Antibody nanoparticle conjugate-based targeted immunotherapy for non-small cell lung cancer","volume":"10","author":"Saha","year":"2024","journal-title":"Sci Adv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1755589\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:04:06Z","timestamp":1779775446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1755589\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2026.1755589"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1755589","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"1755589"}}